Subscribe To
Pfizer, biontech begin omicron-specific covid-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-...
January 25, 2022, 8:36 am
Pfizer, biontech begin omicron-specific covid-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-...
January 25, 2022, 8:36 am
Clinical trials begin for pfizer and biontech's omicron-specific covid shot
The study will evaluate the safety and efficacy of a new shot designed to target the omicron coronavirus variant, which can evade some of the protecti...
January 25, 2022, 7:23 am
Clinical trials begin for pfizer and biontech's omicron-specific covid shot
The study will evaluate the safety and efficacy of a new shot designed to target the omicron coronavirus variant, which can evade some of the protecti...
January 25, 2022, 7:23 am
Clinical trials begin for pfizer and biontech's omicron-specific covid shot
The study will evaluate the safety and efficacy of a new shot designed to target the omicron coronavirus variant, which can evade some of the protecti...
January 25, 2022, 7:23 am
Johnson & johnson's fy21 covid-19 vaccine sales below expectations
Johnson & Johnson (NYSE: JNJ) has reported Q4 adjusted earnings of $2.13 per share, up 14.5% Y/Y over the $1.86 posted a year ago and marginally ah...
January 25, 2022, 7:14 am
Johnson & johnson's fy21 covid-19 vaccine sales below expectations
Johnson & Johnson (NYSE: JNJ) has reported Q4 adjusted earnings of $2.13 per share, up 14.5% Y/Y over the $1.86 posted a year ago and marginally ah...
January 25, 2022, 7:14 am
Johnson & johnson's fy21 covid-19 vaccine sales below expectations
Johnson & Johnson (NYSE: JNJ) has reported Q4 adjusted earnings of $2.13 per share, up 14.5% Y/Y over the $1.86 posted a year ago and marginally ah...
January 25, 2022, 7:14 am
Pfizer and biontech launch clinical study of covid vaccine targeting omicron
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March....
January 25, 2022, 6:45 am
Pfizer and biontech launch clinical study of covid vaccine targeting omicron
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March....
January 25, 2022, 6:45 am
Pfizer and biontech launch clinical study of covid vaccine targeting omicron
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March....
January 25, 2022, 6:45 am
J&j expects up to $3.5 billion in covid vaccine sales this year
Johnson & Johnson on Tuesday forecast $3 billion-$3.5 billion in revenue for its COVID-19 vaccine this ...
January 25, 2022, 6:29 am
J&j expects up to $3.5 billion in covid vaccine sales this year
Johnson & Johnson on Tuesday forecast $3 billion-$3.5 billion in revenue for its COVID-19 vaccine this ...
January 25, 2022, 6:29 am
J&j expects up to $3.5 billion in covid vaccine sales this year
Johnson & Johnson on Tuesday forecast $3 billion-$3.5 billion in revenue for its COVID-19 vaccine this ...
January 25, 2022, 6:29 am
Britain needs 6,000 more volunteers to take merck's covid-19 pill mainstream
Britain must find a further 6,000 people to trial Merck's (Coronavirus) COVID-19 antiviral pill to gauge how best to roll it out on a larger scale, Re...
January 25, 2022, 6:14 am
Britain needs 6,000 more volunteers to take merck's covid-19 pill mainstream
Britain must find a further 6,000 people to trial Merck's (Coronavirus) COVID-19 antiviral pill to gauge how best to roll it out on a larger scale, Re...
January 25, 2022, 6:14 am
Britain needs 6,000 more volunteers to take merck's covid-19 pill mainstream
Britain must find a further 6,000 people to trial Merck's (Coronavirus) COVID-19 antiviral pill to gauge how best to roll it out on a larger scale, Re...
January 25, 2022, 6:14 am
Novavax appears to be running out of options
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an ab...
January 25, 2022, 6:00 am
Novavax appears to be running out of options
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an ab...
January 25, 2022, 6:00 am
Novavax appears to be running out of options
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an ab...
January 25, 2022, 6:00 am